2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1205839552 M.D.
Verify on CMS →

MARK GERSMAN, M.D.

Retina Specialist (Ophthalmology) Physician in CANTON, Ohio. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
562
Medicare Part D claims · 193 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
48%
generic claims · 52% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.8/100
▲ 16 pts above national avg 83.1 · [object Object]
Industry payments
$774.95
29 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARK GERSMAN, M.D. reported a CMS MIPS final score of 98.8/100 — above the 83.1 national average — and filed 562 Medicare Part D claims in 2023.

98.8/100
MIPS score · +16 vs avg
562
Part D claims, 2023
48%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK GERSMAN, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

99 Top 11% higher than 89% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK GERSMAN, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARK GERSMAN, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 05/31/2005

NPI 1205839552

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

562 1% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

98.8/100 15.700000000000003% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Ohio

How Retina Specialist (Ophthalmology) Physician compares to other specialties among Ohio providers

Ohio providers

Retina Specialist (Ophthalmology) Physician share within Ohio

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within Ohio

Medicare quality performance — MIPS

MARK GERSMAN, M.D.'s 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
98.8/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 98.8/100 vs national avg 83.1

0%100%National avg83%98.8%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 98.8/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK GERSMAN, M.D. appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding M.D. credentials at 4676 DOUGLAS CIR NW, CANTON, OH, 44718, with a listed phone of (330) 494-1116. NPI 1205839552 was issued on 05/31/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GERSMAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 562 prescription claims written by this provider, covering 193 Medicare beneficiaries and totaling roughly $26K in drug spend, split 52% brand-name and 48% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.8/100 for the 2023 performance year (Quality 100), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4676 DOUGLAS CIR NW
CANTON, OH 44718

Provider Details

NPI 1205839552
Specialty Retina Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Male
NPI Issued 05/31/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

98.8
Final Score
Avg: 83.1
100
Quality
96
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK GERSMAN, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

VITREO-RETINAL CONSULTANTS, INC.
CANFIELD, OH
WOOSTER OPHTHALMOLOGISTS, INC.
WOOSTER, OH

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK GERSMAN, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$775

Largest payer

Apellis Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Ohio OMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~48K Ohio medical licensees in 2023 — they are NOT specific to MARK GERSMAN, M.D.. To verify MARK GERSMAN, M.D.'s current license status, search the OMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

158
Total board actions, Ohio 2023
Across 154 cases
3.29
Actions per 1,000 licensees
Ohio statewide rate
probation
Most common action type
56 cases

OMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Ohio disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Brand-heavy

MARK GERSMAN, M.D. — brand share 52.0%
Specialty average (est.)

52% brand-name claims vs 48% generic, on 562 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

562
Total Claims
$26K
Total Drug Cost
193
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
737
Total Day Supply
18,685
Brand vs Generic
52% brand / 48% generic
Brand Drug Cost
$19K
Generic Drug Cost
$7K

Patient Demographics

Average Patient Age
73.7 years
Avg HCC Risk Score
1.28
Gender Split
49% female / 51% male
Age Distribution
<65: 16, 65-74: 84, 75-84: 73, 85+: 20

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MARK GERSMAN, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
200
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
94
Ofloxacin
83
Latanoprost
44
Ketorolac Tromethamine
34
Timolol Maleate
18
Moxifloxacin
Moxifloxacin Hcl
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How MARK GERSMAN, M.D. fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

MARK GERSMAN, M.D.'s 562 claims are above the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in Ohio

Other clinicians with the same primary specialty enrolled in Ohio, drawn from the same CMS NPPES roster as GERSMAN.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK GERSMAN, M.D.'s specialty?
MARK GERSMAN, M.D. specializes in Retina Specialist (Ophthalmology) Physician and practices in CANTON, Ohio. Credentials: M.D..
How much does MARK GERSMAN, M.D. prescribe under Medicare Part D?
In 2023, MARK GERSMAN, M.D. wrote 562 Medicare Part D claims totaling $26K in drug costs for 193 beneficiaries.
What is MARK GERSMAN, M.D.'s Medicare quality score?
MARK GERSMAN, M.D. has a CMS MIPS Final Score of 98.8/100 (Quality: 100). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK GERSMAN, M.D. located?
MARK GERSMAN, M.D. is located at 4676 DOUGLAS CIR NW, CANTON, OH, 44718. Phone: (330) 494-1116.
What is MARK GERSMAN, M.D.'s NPI number?
MARK GERSMAN, M.D.'s National Provider Identifier (NPI) is 1205839552, issued on 05/31/2005.
Does MARK GERSMAN, M.D. prescribe more brand-name or generic drugs?
MARK GERSMAN, M.D.'s prescribing is 52% brand-name and 48% generic drugs by claim count, with $19K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does MARK GERSMAN, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK GERSMAN, M.D.'s most frequently prescribed drugs include Prednisolone Acetate, Neomycin-Polymyxin-Dexameth, Ofloxacin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK GERSMAN, M.D. accept Medicare?
MARK GERSMAN, M.D. appears in CMS Medicare data with 562 Part D claims and 193 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK GERSMAN, M.D.'s credentials?
MARK GERSMAN, M.D.'s NPI is 1205839552 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology